Skip to main content
SpringerLink
Log in

Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thyrotropin-secreting pituitary adenomas (TSH-omas) are rare tumors (0.5% of all pituitary adenomas) showing an invasive behavior and usually sporadic, although a few cases are associated with multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant inherited syndrome. This disorder is linked to loss of heterozygosity (LOH) on 11q13 and inactivating mutations of MEN1 gene, which is located in the same chromosomal region. As other types of anterior pituitary adenomas, TSH-omas are the result of a monoclonal outgrowth where the intrinsic genetic defects involving oncogenes or tumor suppressor genes occur in a progenitor cell. However, so far no activating mutations of particular oncogenes or inactivating mutations of tumor suppressor genes have been identified. Starting from the observation that 3–30% of sporadic pituitary adenomas show LOH on 11q13, and that allelic losses on the long arms of chromosome 11, beside 10 and 13, are significantly associated with the transition from the non-invasive to the invasive phenotype, we decided to investigate LOH on 11q13 and mutations of menin in a large series of TSH-omas. Thirteen tumors were evaluated. DNA was extracted from tumors by standard methods and genomic DNA from peripheral blood leukocytes was used as control. LOH was screened by using 3 polymorphic markers on 11q13: D11S956, PYGM, INT-2. In 3 out of 15 cases we could demonstrate LOH on 11q13, but none of the tumors showed menin mutation after sequence analysis. These data strongly suggest that menin does not play a causative role in the development of TSH-omas, and are in agreement with other studies demonstrating a limited role of menin in pituitary sporadic tumorigenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beck-Peccoz P., Bruker-Davis F., Persani L., Smallridge R.C., Weintraub B.D. Thyrotropin secreting pituitary tumors. Endocr. Rev. 1996, 17: 610–638.

    CAS  PubMed  Google Scholar 

  2. Alexander J.M., Biller M.B.K., Bikkal H., Zervas N.T., Arnold A., Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest. 1990, 86: 336–340.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Herman V., Fagin J., Gonsky R., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab. 1990, 71: 1427–1433.

    Article  CAS  PubMed  Google Scholar 

  4. Mantovani S., Beck-Peccoz P., Saccomanno K., Spada A., Faglia G., Barbetti F. TSH-secreting pituitary adenomas are monoclonal in origin. In Book of Abstracts of the 77th Annual Meeting of the Endocrine Society, June 14–17, 1995, Washington, DC, Abstract P2–485, p. 412.

    Google Scholar 

  5. Vallar L., Spada V., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987, 330: 566–568.

    Article  CAS  PubMed  Google Scholar 

  6. Landis C., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989, 340: 692–696.

    Article  CAS  PubMed  Google Scholar 

  7. Lyons J., Landis C.A., Harsh G., Vallar L., Grünewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H.R, McCormick F. Two G protein oncogenes in human endocrine tumors. Science 1990, 249: 655–659.

    Article  CAS  PubMed  Google Scholar 

  8. Boggil M.D., Jenkinson S., Pistorello M., Boscaro M., Scanarini M., Mc Ternan P., Perrett C.W., Thakker R.V., Clayton R.N. Molecular genetic studies of sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 1994, 78: 387–392.

    Google Scholar 

  9. Dong Q., Bruker-Davis F., Weintraub B.D., Smallridge R.C., Carr F.E., Battey J., Spiegel A.M., Shenker A. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the Gaq, Ga11, Gas, or thyrotropin-releasing hormone receptor genes. J. Clin. Endocrinol. Metab. 1996, 81: 1134–1140.

    CAS  PubMed  Google Scholar 

  10. Delhase M., Vergani P., Malur A., Velkeniers B., Teugels E., Trouillas J., Hooghe-Peters E.L. Pit1/GHF-1 expression in pituitary adenomas. Further analogy between humans adenomas and rat tumors. J. Mol. Endocrinol. 1993, 11: 129–139.

    Article  CAS  PubMed  Google Scholar 

  11. Pellegrini I., Barlier A., Gunz G., Figarella-Branger D., Enjalbert A., Grisoli F., Jaquet P. Pit-1 gene expression in the human pituitary and pituitary adenomas. J. Clin. Endocrinol. Metab. 1994, 79: 189–196.

    CAS  PubMed  Google Scholar 

  12. Sanno N., Teramoto A., Matsuno A., Inada K., Itoh J., Osamura R.J. Clinical and immunoistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mod. Pathol. 1994, 7: 893–899.

    CAS  PubMed  Google Scholar 

  13. Sanno N., Teramoto A., Matsuno A., Takekoshi S., Osamura R.J. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 1995, 80: 2518–2522.

    CAS  PubMed  Google Scholar 

  14. Woloschak M., Roberts J.L., Post K. c-myc, c-fos, and c-myb gene expression in human pituitary adenomas. J. Clin. Endocrinol. Metab. 1992, 79: 253–257.

    Google Scholar 

  15. Sumi T., Stefaneanu L., Kovacs K., Asa S.L., Rindi G. Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr. Pathol. 1993, 4: 95–99.

    Article  Google Scholar 

  16. Bates A.S., Talbot A.J., Buckley N., Bickness J., Farrell W.E., Clayton R.N. Tumor suppressor genes as a marker of invasive behavior in pituitary tumors. J. Endocrinol. 1995, (Suppl. 1) 144.

    Google Scholar 

  17. Bates A.S., Farrell W.E., Bicknell E.J., McNicol A.M., Talbot A.J., Broome J., Perret C.W., Thakker R.V., Clayton R.N. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J. Clin. Endocrinol. Metab. 1997, 82: 818–824.

    CAS  PubMed  Google Scholar 

  18. Dong Q., Debelenko L.V., Chandrasekharappa S.C., Emmert-Buck M., Zhuang Z., Guru S.C., Manickam P., Skarulis M., Lubensky I.A., Liotta L.A., Collins F.S., Marx S.J., Spiegel A.M. Loss of heterozygosity at 11q13 analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors of subjects with familial multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 1997, 82: 1416–1420.

    Article  CAS  PubMed  Google Scholar 

  19. Zhuang Z., Ezzat S.Z., Vortmeyer A.O., Weil R., Oldfield E.H., Park W-S.S., Huang S., Agarwal S.K., Guru S.C., Manickam P., Debelenko L.V., Kester M.B., Olufemi S.-E., Heppner C., Crabtree J.S., Burns A.L., Spiegel A.M., Marx S.J., Chandrase-kharappa S.C., Collins F.S., Emmert-Buck M.R., Liotta L.A., Asa S.L., Lubensky I.A. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 1997, 57: 5446–5451.

    CAS  PubMed  Google Scholar 

  20. Prezant T.R., Levine J., Melmed S. Molecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 1998, 83: 1338–1391.

    Article  Google Scholar 

  21. Poncin J., Stevenaert A., Beckers A. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur. J. Endocrinol. 1999, 140: 573–576.

    Article  CAS  PubMed  Google Scholar 

  22. Larsson C., Calender A., Grimmond S., Giraud S., Hayward N.K., Teh F., Farnebo F. Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J. Intern. Med. 1995, 238: 239–244.

    Article  CAS  PubMed  Google Scholar 

  23. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S-E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim J.S. Heppner C., Dong Q., Spiegel A.M., Burns A.L., Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276: 404–407.

    Article  CAS  PubMed  Google Scholar 

  24. Agarwal S., Kester M.B., Debelenko L.V., Heppner C., Emmert-Buck M., Skarulis M.C., Doppman J.L., Kim Y.S., Lubensky I.A., Zhuang Z., Green J.S., Guru S.C., Manickam P., Olufemi S.-E., Liotta L.A., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Burns A.L., Marx S.J. Germline mutations of the MEN1 gene in familial MEN1 and related states. Hum. Mol. Genet. 1997, 6: 1169–1175.

    Article  CAS  PubMed  Google Scholar 

  25. Tanaka C., Kimura T., Yang P., Moritani M., Yamaoka T., Yamada S., Sano T., Yoshimoto K., Itakura M. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J. Clin. Endocrinol. Metab. 1998, 83: 2631–2634.

    CAS  PubMed  Google Scholar 

  26. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D.S., Gnarra J.R., Linehan W.M. Silencing of the VHL tumor-suppressor gene by DNA metylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 1994, 91: 9700–9704.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., Baylin S.B., Sidransky D. 5′ CpG island methylation is associated with tran-scriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nat. Med. 1995, 1: 686–692.

    Article  CAS  PubMed  Google Scholar 

  28. Asa S.L., Somers K., Ezzat S. The MEN1 gene is rarely downregulated in pituitary adenomas. J. Clin. Endocrinol. Metab. 1998, 83: 3210–3212.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore IRCCS, Via F. Sforza 35, 20122, Milano, Italy

    C. Asteria &  Paolo Beck-Peccoz

  2. Department of Internal Medicine, Bellaria Hospital, Bologna, Italy

    M. Anagni

  3. Istituto Auxologico Italiano IRCCS, Milan, Italy

    L. Persani

Authors
  1. C. Asteria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Anagni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Persani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Beck-Peccoz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Beck-Peccoz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asteria, C., Anagni, M., Persani, L. et al. Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas. J Endocrinol Invest 24, 796–801 (2001). https://doi.org/10.1007/BF03343929

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343929

Key-words

Search

Navigation